Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisaftoclax for Prevention of Differentiation Syndrome in APL
NCT07597941Phase 3Not yet recruiting
- Sponsor
- The Affiliated People’s Hospital of Ningbo University
- Start
- Jul 2026
- Primary completion
- Jun 2028
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of lisaftoclax in differentiation syndrome (DS), sponsored by The Affiliated People’s Hospital of Ningbo University. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
lisaftoclax
03
Conditions
differentiation syndrome (DS)
Beyond the preview
Go deeper on NCT07597941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07597941.